FDA, J&J set to announce Baltimore vaccine plant ready to reopen

WASHINGTON — The Food and Drug Administration and vaccine maker Johnson & Johnson expect to announce as early as Friday that contamination problems at a COVID-19 vaccine plant in Baltimore are resolved, clearing the way for millions more doses to become available.

Vaccine production at the plant run by contract manufacturer Emergent BioSolutions Inc. 
EBS,
+0.61%

 was halted after unsanitary conditions led to contamination of J&J
JNJ,
-0.15%

vaccines. The facility made vaccine substance and finished vaccine doses for J&J and AstraZeneca 
AZN,
+0.62%

 PLC.

Source link

READ ALSO :  I want to retire in Texas and near freshwater on $4,000 a month — where should I go?

Leave a Comment